Floatz logo

34 assets in Down Syndrome

Therapeutic assets addressing Down Syndrome, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Vincristine Sulfate
Down Syndrome
National Cancer Institute (NCI)P3BB (69)
Mercaptopurine Anhydrous
Down Syndrome
National Cancer Institute (NCI)P3BB (68)
Pegaspargase
Down Syndrome
National Cancer Institute (NCI)P3BB (68)
Cytarabine
Down Syndrome
Federal Research Institute of Pediatric Hematology, Oncology and ImmunologyP3BB (67)
Asparaginase
Down Syndrome
National Hospital Organization Nagoya Medical CenterP3BB (66)
Blinatumomab
Down Syndrome
National Cancer Institute (NCI)P3BB (66)
Crisantaspase
Down Syndrome
National Cancer Institute (NCI)P3BB (66)
Cyclophosphamide
Down Syndrome
National Cancer Institute (NCI)P3BB (66)
Daunomycin
Down Syndrome
National Hospital Organization Nagoya Medical CenterP3BB (66)
Dexasone
Down Syndrome
National Cancer Institute (NCI)P3BB (66)
Prednisolone
Down Syndrome
National Cancer Institute (NCI)P3BB (66)
Donanemab
Down Syndrome
Michael Rafii, MD, PhDP4BB (65)
Adriamycin
Down Syndrome
National Cancer Institute (NCI)P3BB (64)
Thioguanine Anhydrous
Down Syndrome
National Cancer Institute (NCI)P3BB (64)
Methotrexate
Down Syndrome
National Cancer Institute (NCI)P3B (63)
Etoposide
Down Syndrome
Children's Oncology GroupP3B (60)
Idarubicin
Down Syndrome
Federal Research Institute of Pediatric Hematology, Oncology and ImmunologyP3B (60)
Mitoxantrone
Down Syndrome
Children's Oncology GroupP3B (60)
mk-6240
Down Syndrome
LuMind IDSC FoundationP3B (60)
Prednisone
Down Syndrome
National Cancer Institute (NCI)P3B (60)
Gnrh
Down Syndrome
Nelly PitteloudP2/3B (57)
Gonadorelin
Down Syndrome
Nelly PitteloudP2/3B (57)
Physiologic Sodium Chloride Solution
Down Syndrome
Nelly PitteloudP2/3B (56)
Aci-24
Down Syndrome
AC Immune SAP2CCC (53)
Calaspargase Pegol
Down Syndrome
National Cancer Institute (NCI)P2CCC (53)
Epirubicin
Down Syndrome
National Hospital Organization Nagoya Medical CenterP2CCC (53)
Feobv F-18
Down Syndrome
Vanderbilt University Medical CenterP2CCC (53)
Hydrocortisone
Down Syndrome
National Cancer Institute (NCI)P2CCC (53)
Nivolumab
Down Syndrome
National Cancer Institute (NCI)P2CCC (53)
(+)-Vincristine
Down Syndrome
National Hospital Organization Nagoya Medical CenterP2CCC (53)
Leucettinib-21
Down Syndrome
Perha PharmaceuticalsP1CC (47)
ion269
Down Syndrome
Ionis Pharmaceuticals, Inc.P1CC (43)
Mib-626
Down Syndrome
Brigham and Women's HospitalP1CC (43)
Aci-24.060
Down Syndrome
AC Immune SAP1/2NR ()